Thomas v. Takeda Pharmaceuticals USA, Inc. et al

Filing 10

ORDER Granting Joint 9 Motion for a Stay Pending the Judicial Panel of Multidistrict Litigation's Resolution of the Motion to Transfer signed by Chief Judge Lawrence J. O'Neill on 01/10/2017. (Flores, E)

1
2

IN THE UNITED STATES DISTRICT COURT

3

FOR THE EASTERN DISTRICT OF CALIFORNIA

4
5

SHARRON THOMAS,

6

Plaintiff,

7

9
10
11
12
13
14
15
16

Hon. Lawrence J. O’Neill
Courtroom 4

v.

8

TAKEDA PHARMACEUTICALS USA,
INC., TAKEDA PHARMACEUTICALS
AMERICA, INC.; TAKEDA
PHARMACEUTICALS
INTERNATIONAL INC.; TAKEDA
DEVELOPMENT CENTER AMERICAS,
INC.; TAKEDA GMBH; TAKEDA
PHARMACEUTICAL COMPANY
LIMITED; TAKEDA
PHARMACEUTICAL COMPANY
LIMITED,
Defendants.

17

CASE NO. 1:16-CV-01566-LJOEPGx

ORDER GRANTING JOINT
MOTION FOR A STAY
PENDING THE JUDICIAL
PANEL ON MULTIDISTRICT
LITIGATION’S RESOLUTION
OF THE MOTION TO
TRANSFER PURSUANT TO 28
U.S.C. § 1407

Action Filed: October 14, 2016
Trial Date:
None Set

18
19

The Joint Motion For A Stay Pending The Judicial Panel On Multidistrict

20

Litigation’s Resolution Of The Motion To Transfer Pursuant To 28 U.S.C. § 1407

21

submitted by the parties, Takeda Pharmaceuticals, U.S.A., Inc., Takeda

22

Pharmaceuticals International, Inc., Takeda Development Center Americas, Inc.

23

and Takeda Pharmaceuticals America, Inc. (“Takeda”) and Plaintiff Sharron

24

Thomas (“Plaintiff”) on January 9, 2017, the Court, having received all evidence

25

and the matter having been submitted, ORDERS as follows:

26

IT IS HEREBY ORDERED that:

27

1.

28
1
2

All proceedings in this action are stayed pending the decision of the

Judicial Panel on Multidistrict Litigation (“JPML”) on the motion Plaintiff’s

1

counsel filed on October 17, 2016 to transfer this action and fifteen others to a

2

multidistrict litigation, which Plaintiff’s counsel requested be established in the

3

United States District Court for the Middle District of Louisiana. See Ex. 1,

4

Memorandum in Support of Plaintiffs’ Motion for Transfer of Actions to the

5

United States District Court for the Middle District of Louisiana Pursuant to 28

6

U.S.C. § 1407 and JPML Rule 7.2 for Coordinated Pretrial Proceedings; and Ex. 2,

7

In re: Proton-Pump Inhibitor Product Liability Litigation (MDL No. 2757),

8

Schedule of Actions.

9

2.

The Scheduling Conference set for January 26, 2017, along with

10

corresponding deadlines for the parties to meet and confer and submit a Joint

11

Scheduling Report in advance of the Scheduling Conference, is adjourned,

12

including a stay of all corresponding deadlines for the parties to hold a discovery

13

conference and submit a Joint Scheduling Report, until after the JPML decides the

14

motion requesting an MDL.

15
16
17

IT IS SO ORDERED.
Dated:

January 10, 2017

/s/ Lawrence J. O’Neill _____
UNITED STATES CHIEF DISTRICT JUDGE

18
19
20
21
22
23
24
25
26
27
28
1
2